Literature DB >> 9818861

Predicting neurologic deterioration in patients with cerebellar hematomas.

E K St Louis1, E F Wijdicks, H Li.   

Abstract

BACKGROUND: Patients with cerebellar hematomas may appear stable but may worsen suddenly. Whether certain clinical or CT scan findings predict worsening is not known.
METHODS: We reviewed clinical and neuroimaging data in 72 patients with cerebellar hematomas at the Mayo Clinic from 1973 through 1993 to identify predictive features for neurologic deterioration. Patients presenting in coma and patients with vascular malformations or malignancies were excluded. Data were analyzed using chi-square or Fisher's exact test, with calculation of odds ratios with 95% confidence intervals. Multivariate logistic regression analysis was performed on appropriate variables.
RESULTS: Thirty-three patients (46%) deteriorated, with a decrease in level of consciousness, new brainstem signs, or worsened motor response on the Glasgow Coma Scale. Clinical and neuroradiologic predictors for neurologic deterioration at p < 0.05 were admission systolic blood pressure greater than 200 mm Hg, pinpoint pupils and abnormal corneal or oculocephalic reflexes, hemorrhage extending into the vermis, hematoma size more than 3 cm in diameter, brainstem distortion, intraventricular hemorrhage, upward herniation, and acute hydrocephalus. Multivariate analysis demonstrated that hemorrhage located in the vermis (p = 0.03) and acute hydrocephalus (p = 0.0006) on admission CT scanning independently predicted deterioration.
CONCLUSION: Patients with a cerebellar vermian hematoma or acute hydrocephalus are at high risk for neurologic deterioration. These patients should be carefully monitored and are more likely to require consideration for neurosurgical intervention.

Entities:  

Mesh:

Year:  1998        PMID: 9818861     DOI: 10.1212/wnl.51.5.1364

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  The postpartum period of pregnancy worsens brain injury and functional outcome after cerebellar hemorrhage in rats.

Authors:  Tim Lekic; Robert P Ostrowski; Hidenori Suzuki; Anatol Manaenko; William Rolland; Nancy Fathali; Jiping Tang; John H Zhang
Journal:  Acta Neurochir Suppl       Date:  2011

2.  Cerebellar strokes: a clinical outcome review of 79 cases.

Authors:  Z X Ng; W R Yang; E Seet; K M Koh; K J Teo; S W Low; N Chou; T T Yeo; N Venketasubramanian
Journal:  Singapore Med J       Date:  2015-03       Impact factor: 1.858

3.  Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.

Authors:  A I Qureshi; Y Y Palesch
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

Review 4.  Critical Care Management of Acute Ischemic Stroke.

Authors:  Matthew B Bevers; W Taylor Kimberly
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

5.  Characterization of the brain injury, neurobehavioral profiles, and histopathology in a rat model of cerebellar hemorrhage.

Authors:  Tim Lekic; William Rolland; Richard Hartman; Joel Kamper; Hidenori Suzuki; Jiping Tang; John H Zhang
Journal:  Exp Neurol       Date:  2010-09-29       Impact factor: 5.330

Review 6.  Recurrent cerebellar hemorrhage: case report and review of the literature.

Authors:  Yung-Tsan Wu; Ming-Fu Hsieh; Heng-Yi Chu; Shao-Chi Lu; Shin-Tsu Chang; Tsung-Ying Li
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

7.  Hyperglycemia as a predictor of poor outcome at discharge in patients with acute spontaneous cerebellar hemorrhage.

Authors:  Yung-Tsan Wu; Tsung-Ying Li; Shao-Chi Lu; Liang-Cheng Chen; Heng-Yi Chu; Shang-Lin Chiang; Shin-Tsu Chang
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

8.  Predictors of first-week mortality in patients with acute spontaneous cerebellar hemorrhage.

Authors:  Yung-Tsan Wu; Tsung-Ying Li; Shang-Lin Chiang; Heng-Yi Chu; Shin-Tsu Chang; Liang-Cheng Chen
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

Review 9.  Intracerebral haemorrhage.

Authors:  Adnan I Qureshi; A David Mendelow; Daniel F Hanley
Journal:  Lancet       Date:  2009-05-09       Impact factor: 79.321

10.  Treatment of cerebellar masses.

Authors:  Mahmut Edip Gurol; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.